Experts Urge Settling Japan Minamata Disease Compensation Dispute
This article was originally published in PharmAsia News
A panel of experts called for the Japan government to settle a division between its Supreme Court and the Environment Ministry over criteria for recognizing patients of mercury poisoning as having Minamata disease.
You may also be interested in...
France has announced a number of emergency measures to protect drug supplies threatened by the spread of the coronavirus.
Major generics companies have donated hydroxychloroquine sulfate doses for research and treatment of coronavirus. Companies are also donating hand sanitizer and personal protective equipment and are preparing to ramp up manufacturing and production.
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?